News

Pharma Company Fresenius Kabi Launches Generic Fertility Treatment

FDA Approves Medicines360’s LILETTA for the Treatment of Heavy Menstrual Bleeding

Freya Biosciences’ FB101 Shows Promise in Treating Vaginal Dysbiosis

Proov’s Confirm PdG Ovulation Test Becomes First Third Party Women’s Health Test Available Through Questhealth.com

Indonesia: SoftBank-backed Digital Health Platform Alodokter Acquires Pregnancy App Diary Bunda

L’Oréal Reveals New Study on the Impact of Hormonal Variations on Women’s Skin

Belgium-based Menstrual Health Supplement Startup Guud Adds $1.7M in Seed Funding to Invest in Growth

What’s New in Femtech This Week? (July 6, 2023)

Kindred Raises $1M in Seed Funding to Scale Its Hybrid Women’s Healthcare Model in the Philippines

Mark Cuban Cost Plus Drug Company Teams Up with Male Fertility Company Posterity Health

FDA Approves Thermo Fisher’s Immunoassays for Risk Assessment of Preeclampsia

Infant Formula Company Bobbie and Breast Pump Company Elvie Launch New Retail Experience to Normalizing Combo Feeding

Femtech Investment Round-up (June 2023)

INVO Bioscience’s INVOcell Device Receives FDA Approval for 5-Day Incubation in Fertility Treatment

Kindbody Adds In-House Genetic Testing with the Launch of Kindlabs

UK-Based Fertility Benefits Startup Fertifa Adds £5M in Seed Funding

Alfie Health Launches AI-Based ObesityRx Platform After Raising $2.1M

Flo Health’s ‘Anonymous Mode’ Feature Is Now Open-Source for Industry-Wide Privacy Protection

What’s New in Femtech This Week? (June 29, 2023)

Celmatix Advances Its Oral Fertility Drug Program in a Promising Step Towards Needle-Free IVF

Women-Led Vertex Ventures HC Launches $200M Fund III to Back Life Sciences and Medtech Companies

New Study by EXHALE Reveals Scarcity of Culturally-Responsive Self-Care Tools for Black Women

DUOS Raises $10M for Its Care Navigation and Support Platform for Aging Adults

Femasys Receives FDA Approval for Clinical Trial of FemBloc, a Non-Surgical Permanent Birth Control Solution